Rekombinanter TNFSF11 (Denosumab Biosimilar) Antikörper

Produktnummer ABIN7200656

Dieser Maus Monoklonal Antikörper detektiert spezifisch TNFSF11 (Denosumab Biosimilar) in FACS und in vivo. Es zeigt Reaktivität gegenüber Proben von Human.

Kurzübersicht für Rekombinanter TNFSF11 (Denosumab Biosimilar) Antikörper (ABIN7200656)

Target: TNFSF11 (Denosumab Biosimilar)

Antikörpertyp: Recombinant Antibody

Fragment: Fab fragment

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser TNFSF11 (Denosumab Biosimilar) Antikörper ist unkonjugiert

Applikation: Flow Cytometry (FACS), In vivo Studies (in vivo)

Güteklasse: Research Grade

Produktdetails anti-TNFSF11 (Denosumab Biosimilar) Antikörper

Verwendungszweck: Denosumab Biosimilar, Human RANKL Monoclonal Antibody

Spezifität: The monoclonal antibody denosumab biosimilar specifically binds to the human RANKL (RANK ligand) protein.

Produktmerkmale: Denosumab, a fully human monoclonal antibody, inhibits the RANKL (RANK ligand) protein, the primary signal for bone removal. Denosumab can be used for the treatment of osteoporosis, treatment-induced bone loss, bone metastases, multiple myeloma, and giant cell tumor of bone.

Aufreinigung: Protein A or G affinity column

Reinheit: >95 % by reducing SDS-PAGE

Sterilität: 0.2 μm filtered

Endotoxin-Niveau: < 1 EU per 1 mg of the protein by the LAL method

Immunogen: The monoclonal antibody denosumab biosimilar was produced in the denosumab biosimilar CHO stable cell line.

Isotyp: IgG2

Anwendungsinformationen

Applikationshinweise: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by denosumab.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: > 3 mg/mL

Buffer: PBS, pH 7.4, no stabilizers or preservatives.

Konservierungsmittel: Without preservative

Lagerung: 4°C,-20 °C

Informationen zur Lagerung: 12 months from date of receipt, -20 to -70°C as supplied. 1 month from date of receipt, 2 to 8°C as supplied.

Haltbarkeit: 12 months

Details zu TNFSF11 (Denosumab Biosimilar)

Target: TNFSF11 (Denosumab Biosimilar)

Andere Bezeichnung: Denosumab Biosimilar

Substanzklasse: Biosimilar